Johnson & Johnson (JNJ) Long-Term Debt Repayments (2009 - 2024)
Johnson & Johnson recorded quarterly Long-Term Debt Repayments of $1.0 million in Q1 2024, up 100.17% quarter-over-quarter from -$582.0 million in Q4 2023, and down 99.8% year-over-year from $500.0 million in Q2 2023.
Johnson & Johnson's Long-Term Debt Repayments history runs 16 years deep, the most recent figure standing at $1.0 million for Q1 2024.
- In Q1 2024, Long-Term Debt Repayments fell 99.8% year-over-year to $1.0 million; the TTM figure through Mar 2024 stood at $601.0 million (down 78.65% YoY), while the FY2025 annual figure was $1.8 billion, up 20.92% from the prior year.
- Long-Term Debt Repayments came in at $1.0 million for Q1 2024 at Johnson & Johnson, up from -$582.0 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $2.1 billion in Q2 2022 to a low of -$582.0 million in Q4 2023.
- A 5-year average of $529.4 million and a median of $500.0 million in 2023 frame the typical range for Long-Term Debt Repayments.
- Across the five-year window, Long-Term Debt Repayments surged 18266.67% in 2020 and tumbled 185.34% in 2023, its largest moves.
- Johnson & Johnson's Long-Term Debt Repayments stood at $551.0 million in 2020, then tumbled by 99.82% to $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then slumped by 58300.0% to -$582.0 million in 2023, then soared by 100.17% to $1.0 million in 2024.
- According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $1.0 million, -$582.0 million, and $500.0 million for Q1 2024, Q4 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 750.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 1.14 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 833.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.77 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 500.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -582.00 Mn |
| Dec 31, 2023 | -582.00 Mn |
| Apr 2, 2023 | 500.00 Mn |
| Apr 2, 2023 | 500.00 Mn |
| Jan 1, 2023 | 682.00 Mn |
| Jan 1, 2023 | 682.00 Mn |
| Oct 2, 2022 | 1.00 Mn |
| Oct 2, 2022 | 1.00 Mn |
| Jul 3, 2022 | 1.63 Bn |
| Jul 3, 2022 | 1.63 Bn |
| Apr 3, 2022 | 2.13 Bn |
| Apr 3, 2022 | 2.13 Bn |
| Oct 3, 2021 | 1.00 Mn |
| Oct 3, 2021 | 1.00 Mn |
| Jul 4, 2021 | 450.00 Mn |
| Jul 4, 2021 | 450.00 Mn |
| Apr 4, 2021 | 1.00 Bn |
| Apr 4, 2021 | 1.00 Bn |
| Jan 3, 2021 | 502.00 Mn |
| Jan 3, 2021 | 502.00 Mn |
| Sep 27, 2020 | 551.00 Mn |
| Sep 27, 2020 | 551.00 Mn |
| Mar 29, 2020 | 11.00 Mn |
| Mar 29, 2020 | 11.00 Mn |
| Dec 29, 2019 | 1.82 Bn |
| Dec 29, 2019 | 1.82 Bn |
| Sep 29, 2019 | 3.00 Mn |
| Sep 29, 2019 | 3.00 Mn |
| Jun 30, 2019 | 3.00 Mn |
| Jun 30, 2019 | 3.00 Mn |
| Mar 31, 2019 | 1.00 Bn |
| Mar 31, 2019 | 1.00 Bn |
| Dec 30, 2018 | 645.00 Mn |
| Dec 30, 2018 | 645.00 Mn |
| Sep 30, 2018 | 901.00 Mn |
| Sep 30, 2018 | 901.00 Mn |
| Jul 1, 2018 | 1.00 Mn |
| Jul 1, 2018 | 1.00 Mn |
| Apr 1, 2018 | 8.00 Mn |
| Apr 1, 2018 | 8.00 Mn |
| Dec 31, 2017 | 753.00 Mn |
| Dec 31, 2017 | 753.00 Mn |
| Oct 1, 2017 | 1.01 Bn |
| Oct 1, 2017 | 1.01 Bn |
| Jul 2, 2017 | 13.00 Mn |
| Jul 2, 2017 | 13.00 Mn |
| Apr 2, 2017 | 2.00 Mn |
| Apr 2, 2017 | 2.00 Mn |
| Jan 1, 2017 | 2.20 Bn |
| Jan 1, 2017 | 2.20 Bn |
| Apr 3, 2016 | 14.00 Mn |
| Apr 3, 2016 | 14.00 Mn |
| Sep 27, 2015 | 6.00 Mn |
| Sep 27, 2015 | 6.00 Mn |
| Jun 28, 2015 | 5.00 Mn |
| Jun 28, 2015 | 5.00 Mn |
| Mar 29, 2015 | 16.00 Mn |
| Mar 29, 2015 | 16.00 Mn |
| Dec 28, 2014 | 57.00 Mn |
| Dec 28, 2014 | 57.00 Mn |
| Sep 28, 2014 | 10.00 Mn |
| Sep 28, 2014 | 10.00 Mn |
| Jun 29, 2014 | 1.76 Bn |
| Jun 29, 2014 | 1.76 Bn |
| Mar 30, 2014 | 21.00 Mn |
| Mar 30, 2014 | 21.00 Mn |
| Dec 29, 2013 | 62.00 Mn |
| Dec 29, 2013 | 62.00 Mn |
| Sep 29, 2013 | 27.00 Mn |
| Sep 29, 2013 | 27.00 Mn |
| Jun 30, 2013 | 1.50 Bn |
| Jun 30, 2013 | 1.50 Bn |
| Mar 31, 2013 | 1.00 Mn |
| Mar 31, 2013 | 1.00 Mn |
| Dec 30, 2012 | 8.00 Mn |
| Dec 30, 2012 | 8.00 Mn |
| Sep 30, 2012 | 786.00 Mn |
| Sep 30, 2012 | 786.00 Mn |
| Jul 1, 2012 | -20.00 Mn |
| Jul 1, 2012 | -20.00 Mn |
| Apr 1, 2012 | 30.00 Mn |
| Apr 1, 2012 | 30.00 Mn |
| Jan 1, 2012 | -5.00 Mn |
| Jan 1, 2012 | -5.00 Mn |
| Apr 3, 2011 | 3.00 Mn |
| Apr 3, 2011 | 3.00 Mn |
| Oct 3, 2010 | 9.00 Mn |
| Oct 3, 2010 | 9.00 Mn |
| Jul 4, 2010 | 4.00 Mn |
| Jul 4, 2010 | 4.00 Mn |
| Apr 4, 2010 | 8.00 Mn |
| Apr 4, 2010 | 8.00 Mn |
| Jan 3, 2010 | -5.00 Mn |
| Jan 3, 2010 | -5.00 Mn |
| Sep 27, 2009 | 208.00 Mn |
| Sep 27, 2009 | 208.00 Mn |
| Jun 28, 2009 | 7.00 Mn |
| Jun 28, 2009 | 7.00 Mn |
| Mar 29, 2009 | 9.00 Mn |
| Mar 29, 2009 | 9.00 Mn |